U.S., Nov. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07230405) titled 'A Phase II Study of SKB571 in Patients With Lung Cancer' on Nov. 13.
Brief Summary: This is a multicenter, phase II study. The purpose of this study is to evaluate the safety and preliminary anti-tumor activity of SKB571 in patients with advanced non-small cell lung cancer. Eligible subjects will receive SKB571 monotherapy, until radiographic disease progression, intolerable toxicity, discontinuation of study treatment required by the subject, or other protocol-specified treatment discontinuation criteria, whichever occurs first.
Study Start Date: Dec. 13
Study Type: INTERVENTIONAL
Condition:
Lung Cancer (Non-Small Cell)
Interv...